These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23486879)

  • 1. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.
    Graf WD; Nagel SK; Epstein LG; Miller G; Nass R; Larriviere D
    Neurology; 2013 Mar; 80(13):1251-60. PubMed ID: 23486879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.
    Rothman SM
    Neurology; 2013 Oct; 81(17):1558. PubMed ID: 24145884
    [No Abstract]   [Full Text] [Related]  

  • 4. Addressing the problem of ADHD medication as neuroenhancements.
    Graf WD; Miller G; Nagel SK
    Expert Rev Neurother; 2014 May; 14(5):569-81. PubMed ID: 24738763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive enhancement in children and adolescents: is it in their best interests?
    Gaucher N; Payot A; Racine E
    Acta Paediatr; 2013 Dec; 102(12):1118-24. PubMed ID: 24033708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADHD and stimulant drug treatment: what can the children teach us?
    Erler A
    J Med Ethics; 2013 Jun; 39(6):357-8. PubMed ID: 23689793
    [No Abstract]   [Full Text] [Related]  

  • 7. Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee.
    Larriviere D; Williams MA; Rizzo M; Bonnie RJ;
    Neurology; 2009 Oct; 73(17):1406-12. PubMed ID: 19776378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
    Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
    Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication for children with attentional disorders. American Academy of Pediatrics Committee on Children With Disabilities and Committee on Drugs.
    Pediatrics; 1996 Aug; 98(2 Pt 1):301-4. PubMed ID: 8692637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For).
    Isaacs D
    J Paediatr Child Health; 2006 Sep; 42(9):544-7. PubMed ID: 16925542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people.
    Boot BP; Partridge B; Hall W
    Neurocase; 2012 Jun; 18(3):181-4. PubMed ID: 22007842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (Against).
    Efron D
    J Paediatr Child Health; 2006 Sep; 42(9):548-51. PubMed ID: 16925543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ethics of neuroenhancement.
    Chatterjee A
    Handb Clin Neurol; 2013; 118():323-34. PubMed ID: 24182389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assent as an ethical imperative in the treatment of ADHD.
    Koshy AJ; Sisti DA
    J Med Ethics; 2015 Dec; 41(12):977-81. PubMed ID: 26112613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valid informed consent and participative decision-making in children with cancer and their parents: a report of the SIOP Working Committee on psychosocial issues in pediatric oncology.
    Spinetta JJ; Masera G; Jankovic M; Oppenheim D; Martins AG; Ben Arush MW; van Dongen-Melman J; Epelman C; Medin G; Pekkanen K; Eden T;
    Med Pediatr Oncol; 2003 Apr; 40(4):244-6. PubMed ID: 12555253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroenhancement in healthy subject? A French case study].
    Micoulaud-Franchi JA; Vion-Dury J; Lancon C
    Therapie; 2012; 67(3):213-21. PubMed ID: 22874487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.